Gilead Sciences Confirms Breakthrough In Anti-COVID Drug Remdesivir
In a critical announcement that brings hope to millions around the world, Gilead Sciences, which is in the midst of critical Phase 3 trials of the drug Remdesivir in coronavirus patients, said that a breakthrough has been achieved. In Left, Right and Centre, we speak to Dr. Syra Madad, a Pathogens Expert on the reliability of this drug and whether this drug is the cure the world is looking for. We also speak to KT Rama Rao, the working President of TRS, on how Telangana is fighting the highly contagious coronavirus.
NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.
Subscribe for more videos: uskeys.net/user-ndtv
Like us on Facebook: facebook.com/ndtv
Follow us on Twitter: twitter.com/ndtv
Download the NDTV Apps: www.ndtv.com/page/apps
Watch more videos: www.ndtv.com/video?yt